Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJAM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,589
Award facts
- Contract value 100% obligated
- $123,588.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $123,588.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued without set-aside designation on January 13, 2026, represents one of multiple orders under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The company will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with performance anticipated through January 14, 2026.
DMS Pharmaceutical Group's delivery order activity through the PPV-G GEN V program demonstrates the company's established role as a critical supplier within the federal military medical supply chain. The parent IDC, valued at $499.999 billion and awarded November 13, 2025, positions the company as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. DMS Pharmaceutical Group's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables including oncology treatments, immunosuppressants, emergency medications, and surgical products. The company's consistent performance across multiple delivery orders reflects its competitive capability and readiness to fulfill diverse pharmaceutical requirements for military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FEJAM?
SPE2DU26FEJAM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26FEJAM worth?
The government has obligated $123,589 on SPE2DU26FEJAM.
Is contract SPE2DU26FEJAM an order under another contract?
Yes. SPE2DU26FEJAM is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJAM competed?
The extent of competition for SPE2DU26FEJAM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award